Interplay between poxviruses and the cellular ubiquitin/ubiquitin-like pathways

FEBS Letters

Volumn 583, Issue 4, 2009, Pages 607-614

  Zhang, Leiliang ^a   Villa, Nancy Y ^a   McFadden, Grant ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

BTB BACK Kelch; MARCH; Poxvirus; PRANC F box; RING; Ubiquitin

Indexed keywords

ANKYRIN; F BOX PROTEIN; PROTEASOME; PROTEIN P28; RING FINGER PROTEIN; UBIQUITIN; UBIQUITIN PROTEIN LIGASE E3; VIRUS PROTEIN;

CONJUGATION; HOST PATHOGEN INTERACTION; HUMAN; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; SHORT SURVEY;

ANIMALS; FORECASTING; HUMANS; MODELS, BIOLOGICAL; POXVIRIDAE; UBIQUITIN; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITINS;

POXVIRIDAE;

EID: 59849122098     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.01.023     Document Type: Short Survey

References (108)

1. Condit R.C., Moussatche N., and Traktman P. In a nutshell: structure and assembly of the vaccinia virion. Adv. Virus Res. 66 (2006) 31-124
2. Fauquet, C., International Committee on Taxonomy of Viruses and International Union of Microbiological Societies. Virology Division (2005) Virus taxonomy: classification and nomenclature of viruses: eighth report of the International Committee on the Taxonomy of Viruses. Elsevier, Academic Press, San Diego, California, London.
3. Seet B.T., et al. Poxviruses and immune evasion. Ann. Rev. Immunol. 21 (2003) 377-423
4. Wilkinson K.D., Urban M.K., and Haas A.L. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 255 (1980) 7529-7532
5. Edelmann M.J., and Kessler B.M. Ubiquitin and ubiquitin-like specific proteases targeted by infectious pathogens: emerging patterns and molecular principles. Biochim. Biophys. Acta. 1782 (2008) 809-816
6. Kerscher O., Felberbaum R., and Hochstrasser M. Modification of proteins by ubiquitin and ubiquitin-like proteins. Ann. Rev. Cell Dev. Biol. 22 (2006) 159-180
7. Huibregtse J.M., Scheffner M., Beaudenon S., and Howley P.M. A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proc. Natl. Acad. Sci. USA 92 (1995) 2563-2567
8. Joazeiro C.A., Wing S.S., Huang H., Leverson J.D., Hunter T., and Liu Y.C. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286 (1999) 309-312
9. Deshaies R.J. SCF and Cullin/Ring H2-based ubiquitin ligases. Ann. Rev. Cell Dev. Biol. 15 (1999) 435-467
10. Kamura T., Conrad M.N., Yan Q., Conaway R.C., and Conaway J.W. The Rbx1 subunit of SCF and VHL E3 ubiquitin ligase activates Rub1 modification of cullins Cdc53 and Cul2. Genes Dev. 13 (1999) 2928-2933
11. Demand J., Alberti S., Patterson C., and Hohfeld J. Cooperation of a ubiquitin domain protein and an E3 ubiquitin ligase during chaperone/proteasome coupling. Curr. Biol. 11 (2001) 1569-1577
12. Ohmura-Hoshino M., Goto E., Matsuki Y., Aoki M., Mito M., Uematsu M., Hotta H., and Ishido S. A novel family of membrane-bound E3 ubiquitin ligases. J. Biochem. 140 (2006) 147-154
13. Barry M., and Fruh K. Viral modulators of cullin RING ubiquitin ligases: culling the host defense. Sci. STKE 2006 (2006) pe21
14. Lindner H.A. Deubiquitination in virus infection. Virology 362 (2007) 245-256
15. Banks L., Pim D., and Thomas M. Viruses and the 26S proteasome: hacking into destruction. Trends Biochem. Sci. 28 (2003) 452-459
16. Shackelford J., and Pagano J.S. Targeting of host-cell ubiquitin pathways by viruses. Essays Biochem. 41 (2005) 139-156
17. Buller R.M., and Palumbo G.J. Poxvirus pathogenesis. Microbiol. Rev. 55 (1991) 80-122
18. Finlay B.B., and McFadden G. Anti-immunology: evasion of the host immune system by bacterial and viral pathogens. Cell 124 (2006) 767-782
19. Coscoy L., and Ganem D. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97 (2000) 8051-8056
20. Haque M., Ueda K., Nakano K., Hirata Y., Parravicini C., Corbellino M., and Yamanishi K. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. J. Gen. Virol. 82 (2001) 1175-1180
21. Ishido S., Choi J.K., Lee B.S., Wang C., DeMaria M., Johnson R.P., Cohen G.B., and Jung J.U. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity 13 (2000) 365-374
22. Ishido S., Wang C., Lee B.S., Cohen G.B., and Jung J.U. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74 (2000) 5300-5309
23. Mansouri M., et al. The PHD/LAP-domain protein M153R of myxomavirus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J. Virol. 77 (2003) 1427-1440
24. Stevenson P.G., Efstathiou S., Doherty P.C., and Lehner P.J. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. Proc. Natl. Acad. Sci. USA 97 (2000) 8455-8460
25. Guerin J.L., et al. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J. Virol. 76 (2002) 2912-2923
26. Fruh K., Bartee E., Gouveia K., and Mansouri M. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses. Virus Res. 88 (2002) 55-69
27. Aasland R., Gibson T.J., and Stewart A.F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20 (1995) 56-59
28. Saha V., Chaplin T., Gregorini A., Ayton P., and Young B.D. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc. Natl. Acad. Sci. USA 92 (1995) 9737-9741
29. Saurin A.J., Borden K.L., Boddy M.N., and Freemont P.S. Does this have a familiar RING?. Trends Biochem. Sci. 21 (1996) 208-214
30. Collin N., et al. The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology 343 (2005) 171-178
31. Fenner F., and Ratcliffe F.N. Myxomatosis (1965), Cambridge University Press, Cambridge, UK
32. Cameron C., et al. The complete DNA sequence of myxoma virus. Virology 264 (1999) 298-318
33. Bartee E., McCormack A., and Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog. 2 (2006) e107
34. Zuniga M.C., Wang H., Barry M., and McFadden G. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus. Virology 261 (1999) 180-192
35. Barry M., Lee S.F., Boshkov L., and McFadden G. Myxoma virus induces extensive CD4 downregulation and dissociation of p56lck in infected rabbit CD4+ T lymphocytes. J. Virol. 69 (1995) 5243-5251
36. Esteban D.J., and Buller R.M. Ectromelia virus: the causative agent of mousepox. J. Gen. Virol. 86 (2005) 2645-2659
37. Brick D.J., Burke R.D., Minkley A.A., and Upton C. Ectromelia virus virulence factor p28 acts upstream of caspase-3 in response to UV light-induced apoptosis. J. Gen. Virol. 81 (2000) 1087-1097
38. Brick D.J., Burke R.D., Schiff L., and Upton C. Shope fibroma virus RING finger protein N1R binds DNA and inhibits apoptosis. Virology 249 (1998) 42-51
39. Senkevich T.G., Koonin E.V., and Buller R.M. A poxvirus protein with a RING zinc finger motif is of crucial importance for virulence. Virology 198 (1994) 118-128
40. Senkevich T.G., Wolffe E.J., and Buller R.M. Ectromelia virus RING finger protein is localized in virus factories and is required for virus replication in macrophages. J. Virol. 69 (1995) 4103-4111
41. Upton C., Schiff L., Rice S.A., Dowdeswell T., Yang X., and McFadden G. A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories. J. Virol. 68 (1994) 4186-4195
42. Afonso C.L., Tulman E.R., Lu Z., Zsak L., Kutish G.F., and Rock D.L. The genome of fowlpox virus. J. Virol. 74 (2000) 3815-3831
43. Nerenberg B.T., Taylor J., Bartee E., Gouveia K., Barry M., and Fruh K. The poxviral RING protein p28 is a ubiquitin ligase that targets ubiquitin to viral replication factories. J. Virol. 79 (2005) 597-601
44. Taylor J.M., and Barry M. Near death experiences: poxvirus regulation of apoptotic death. Virology 344 (2006) 139-150
45. Huang J., et al. The poxvirus p28 virulence factor is an E3 ubiquitin ligase. J. Biol. Chem. 279 (2004) 54110-54116
46. Crook N.E., Clem R.J., and Miller L.K. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J. Virol. 67 (1993) 2168-2174
47. Srinivasula S.M., and Ashwell J.D. IAPs: what's in a name?. Mol. Cell 30 (2008) 123-135
48. Li Q., Liston P., and Moyer R.W. Functional analysis of the inhibitor of apoptosis (iap) gene carried by the entomopoxvirus of Amsacta moorei. J. Virol. 79 (2005) 2335-2345
49. Li Q., Liston P., Schokman N., Ho J.M., and Moyer R.W. Amsacta moorei Entomopoxvirus inhibitor of apoptosis suppresses cell death by binding Grim and Hid. J. Virol. 79 (2005) 3684-3691
50. Pesin J.A., and Orr-Weaver T.L. Regulation of APC/C activators in mitosis and meiosis. Ann. Rev. Cell Dev. Biol. 24 (2008) 475-499
51. Gmachl M., Gieffers C., Podtelejnikov A.V., Mann M., and Peters J.M. The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex. Proc. Natl. Acad. Sci. USA 97 (2000) 8973-8978
52. Afonso C.L., Tulman E.R., Delhon G., Lu Z., Viljoen G.J., Wallace D.B., Kutish G.F., and Rock D.L. Genome of crocodilepox virus. J. Virol. 80 (2006) 4978-4991
53. Senkevich T.G., Koonin E.V., Bugert J.J., Darai G., and Moss B. The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology 233 (1997) 19-42
54. Delhon G., et al. Genomes of the parapoxviruses ORF virus and bovine papular stomatitis virus. J. Virol. 78 (2004) 168-177
55. McInnes C.J., Wood A.R., Thomas K., Sainsbury A.W., Gurnell J., Dein F.J., and Nettleton P.F. Genomic characterization of a novel poxvirus contributing to the decline of the red squirrel (Sciurus vulgaris) in the UK. J. Gen. Virol. 87 (2006) 2115-2125
56. Lux S.E., John K.M., and Bennett V. Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344 (1990) 36-42
57. Li J., Mahajan A., and Tsai M.D. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45 (2006) 15168-15178
58. Rubtsov A.M., and Lopina O.D. Ankyrins. FEBS Lett. 482 (2000) 1-5
59. Mercer A.A., Fleming S.B., and Ueda N. F-box-like domains are present in most poxvirus ankyrin repeat proteins. Virus Genes 31 (2005) 127-133
60. Shchelkunov S.N., Blinov V.M., and Sandakhchiev L.S. Ankyrin-like proteins of variola and vaccinia viruses. FEBS Lett. 319 (1993) 163-165
61. Bai C., Sen P., Hofmann K., Ma L., Goebl M., Harper J.W., and Elledge S.J. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell 86 (1996) 263-274
62. Ho M.S., Ou C., Chan Y.R., Chien C.T., and Pi H. The utility F-box for protein destruction. Cell Mol. Life Sci. 65 (2008) 1977-2000
63. Mossman K., Lee S.F., Barry M., Boshkov L., and McFadden G. Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J. Virol. 70 (1996) 4394-4410
64. Wang G., et al. Infection of human cancer cells with myxoma virus requires Akt activation via interaction with a viral ankyrin-repeat host range factor. Proc. Natl. Acad. Sci. USA 103 (2006) 4640-4645
65. Johnston J.B., Wang G., Barrett J.W., Nazarian S.H., Colwill K., Moran M., and McFadden G. Myxoma virus M-T5 protects infected cells from the stress of cell cycle arrest through its interaction with host cell cullin-1. J. Virol. 79 (2005) 10750-10763
66. Werden S.J., and McFadden G. The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus. Biochim. Biophys. Acta 1784 (2008) 228-237
67. Werden S.J., Barrett J.W., Wang G., Stanford M.M., and McFadden G. M-T5, the ankyrin repeat, host range protein of myxoma virus, activates Akt and can be functionally replaced by cellular PIKE-A. J. Virol. 81 (2007) 2340-2348
68. Camus-Bouclainville C., Fiette L., Bouchiha S., Pignolet B., Counor D., Filipe C., Gelfi J., and Messud-Petit F. A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J. Virol. 78 (2004) 2510-2516
69. Blanie S., Mortier J., Delverdier M., Bertagnoli S., and Camus-Bouclainville C. M148R and M149R are two virulence factors for myxoma virus pathogenesis in European rabbits. Vet. Res. 40 (2008) 11
70. Sonnberg S., Seet B.T., Pawson T., Fleming S.B., and Mercer A.A. Poxvirus ankyrin repeat proteins are a unique class of F-box proteins that associate with cellular SCF1 ubiquitin ligase complexes. Proc. Natl. Acad. Sci. USA 105 (2008) 10955-10960
71. Sperling K.M., Schwantes A., Schnierle B.S., and Sutter G. The highly conserved orthopoxvirus 68k ankyrin-like protein is part of a cellular SCF ubiquitin ligase complex. Virology 374 (2008) 234-239
72. van Buuren N., Couturier B., Xiong Y., and Barry M. Ectromelia virus encodes a novel family of F-box proteins that interact with the SCF complex. J. Virol. 82 (2008) 9917-9927
73. Bosu D.R., and Kipreos E.T. Cullin-RING ubiquitin ligases: global regulation and activation cycles. Cell Div. 3 (2008) 7
74. Singer J.D., Gurian-West M., Clurman B., and Roberts J.M. Cullin-3 targets cyclin E for ubiquitination and controls S phase in mammalian cells. Genes Dev. 13 (1999) 2375-2387
75. Stogios P.J., Downs G.S., Jauhal J.J., Nandra S.K., and Prive G.G. Sequence and structural analysis of BTB domain proteins. Genome Biol. 6 (2005) R82
76. Wilton B.A., Campbell S., Van Buuren N., Garneau R., Furukawa M., Xiong Y., and Barry M. Ectromelia virus BTB/Kelch proteins, EVM150 and EVM167, interact with cullin-3-based ubiquitin ligases. Virology 374 (2008) 82-99
77. Kochneva G., Kolosova I., Maksyutova T., Ryabchikova E., and Shchelkunov S. Effects of deletions of Kelch-like genes on cowpox virus biological properties. Arch. Virol. 150 (2005) 1857-1870
78. Balinsky C.A., et al. Sheeppox virus Kelch-like gene SPPV-019 affects virus virulence. J. Virol. 81 (2007) 11392-11401
79. Beard P.M., Froggatt G.C., and Smith G.L. Vaccinia virus Kelch protein A55 is a 64 kDa intracellular factor that affects virus-induced cytopathic effect and the outcome of infection in a murine intradermal model. J. Gen. Virol. 87 (2006) 1521-1529
80. Froggatt G.C., Smith G.L., and Beard P.M. Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response. J. Gen. Virol. 88 (2007) 1917-1921
81. Pires de Miranda M., Reading P.C., Tscharke D.C., Murphy B.J., and Smith G.L. The vaccinia virus Kelch-like protein C2L affects calcium-independent adhesion to the extracellular matrix and inflammation in a murine intradermal model. J. Gen. Virol. 84 (2003) 2459-2471
82. Ciehanover A., Hod Y., and Hershko A. A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem. Biophys. Res. Commun. 81 (1978) 1100-1105
83. Hochstrasser M. Evolution and function of ubiquitin-like protein-conjugation systems. Nat. Cell Biol. 2 (2000) E153-E157
84. Johnson E.S. Protein modification by SUMO. Ann. Rev. Biochem. 73 (2004) 355-382
85. Ulrich H.D. The fast-growing business of SUMO chains. Mol. Cell 32 (2008) 301-305
86. Palacios S., Perez L.H., Welsch S., Schleich S., Chmielarska K., Melchior F., and Locker J.K. Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association. Mol. Biol. Cell 16 (2005) 2822-2835
87. Schramm B., and Locker J.K. Cytoplasmic organization of POXvirus DNA replication. Traffic 6 (2005) 839-846
88. Rogan S., and Heaphy S. The vaccinia virus E3L protein interacts with SUMO-1 and ribosomal protein L23a in a yeast two hybrid assay. Virus Genes 21 (2000) 193-195
89. Zhao C., Denison C., Huibregtse J.M., Gygi S., and Krug R.M. Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. USA 102 (2005) 10200-10205
90. Osiak A., Utermohlen O., Niendorf S., Horak I., and Knobeloch K.P. ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol. Cell Biol. 25 (2005) 6338-6345
91. Arimoto K., Konishi H., and Shimotohno K. UbcH8 regulates ubiquitin and ISG15 conjugation to RIG-I. Mol. Immunol. 45 (2008) 1078-1084
92. Guerra S., Lopez-Fernandez L.A., Pascual-Montano A., Munoz M., Harshman K., and Esteban M. Cellular gene expression survey of vaccinia virus infection of human HeLa cells. J. Virol. 77 (2003) 6493-6506
93. Guerra S., Lopez-Fernandez L.A., Pascual-Montano A., Najera J.L., Zaballos A., and Esteban M. Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells. J. Virol. 80 (2006) 985-998
94. Langland J.O., Kash J.C., Carter V., Thomas M.J., Katze M.G., and Jacobs B.L. Suppression of proinflammatory signal transduction and gene expression by the dual nucleic acid binding domains of the vaccinia virus E3L proteins. J. Virol. 80 (2006) 10083-10095
95. Guerra S., Caceres A., Knobeloch K.P., Horak I., and Esteban M. Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog. 4 (2008) e1000096
96. Ponder E.L., and Bogyo M. Ubiquitin-like modifiers and their deconjugating enzymes in medically important parasitic protozoa. Eukaryot. Cell 6 (2007) 1943-1952
97. Katritch V., et al. Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches. J. Comput. Aided Mol. Des. 21 (2007) 549-558
98. Ansarah-Sobrinho C., and Moss B. Role of the I7 protein in proteolytic processing of vaccinia virus membrane and core components. J. Virol. 78 (2004) 6335-6343
99. Webb J.H., Mayer R.J., and Dixon L.K. A lipid modified ubiquitin is packaged into particles of several enveloped viruses. FEBS Lett. 444 (1999) 136-139
100. Chung C.S., Chen C.H., Ho M.Y., Huang C.Y., Liao C.L., and Chang W. Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles. J. Virol. 80 (2006) 2127-2140
101. Afonso C.L., Tulman E.R., Lu Z., Oma E., Kutish G.F., and Rock D.L. The genome of Melanoplus sanguinipes entomopoxvirus. J. Virol. 73 (1999) 533-552
102. Tulman E.R., Afonso C.L., Lu Z., Zsak L., Kutish G.F., and Rock D.L. The genome of canarypox virus. J. Virol. 78 (2004) 353-366
103. Bowie A.G. Insights from vaccinia virus into Toll-like receptor signalling proteins and their regulation by ubiquitin: role of IRAK-2. Biochem. Soc. Trans. 36 (2008) 449-452
104. Harte M.T., et al. The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197 (2003) 343-351
105. Maloney G., Schroder M., and Bowie A.G. Vaccinia virus protein A52R activates p38 mitogen-activated protein kinase and potentiates lipopolysaccharide-induced interleukin-10. J. Biol. Chem. 280 (2005) 30838-30844
106. Schroder M., Baran M., and Bowie A.G. Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKepsilon-mediated IRF activation. EMBO J. 27 (2008) 2147-2157
107. Clegg H.V., Itahana K., and Zhang Y. Unlocking the Mdm2-p53 loop: ubiquitin is the key. Cell Cycle 7 (2008) 287-292
108. Santos C.R., Vega F.M., Blanco S., Barcia R., and Lazo P.A. The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism. Virology 328 (2004) 254-265